Pinehurst Health Associates

09/24/2026

BLIND SPOT: Hundreds of patients are suing the makers of Ozempic, Wegovy and other GLP-1 drugs, alleging the medications caused a rare "eye stroke" linked to permanent vision loss.

The condition, called NAION, cuts blood flow to the optic nerve with no warning and no treatment. A 2024 Harvard study found semaglutide users with type 2 diabetes had roughly four times the relative risk of developing it.

Novo Nordisk called the lawsuits meritless, while the FDA says it is still reviewing the evidence and has not issued a safety warning.

Full story here ⬇️ https://www.foxnews.com/health/popular-weight-loss-drugs-face-lawsuits-rare-eye-stroke-linked-vision-loss

07/18/2025

This Sunday 7/20 , There is an Ice Cream Social 4 to 7 pm at the Beaverdam American Legion Post. sandwiches, pie, and Icecream. all invited, all for free.

06/26/2025

Biden admin failed to investigate dozens of reports

Florida authorities rescue 60 children in Operation Dragon Eye, a multi-agency effort targeting child s*x trafficking, resulting in eight arrests on human trafficking charges.

06/29/2024

Mozart’s piano sonata K448 has been studied by neuroscientists for its enhanced effects on performance. It appears other Mozart works are even more effective and reduce seizure activity. Coppolla et. Al. Epilepsy Behavior. 2018 Jan:78:100-103. “Nine out of 19 patients (13 males and 6 females, aged between 1 and 24years) were randomized to listen to Mozart's sonata in D major for two pianos K448 for 2h/day for 2weeks; other 10 children were randomized on a set of Mozart's compositions. In group 1 (K448), 2/9 children (22.2%) had a ≥75% seizure decrease; two patients had less than 50% seizure reduction, and the other five were unchanged. In group 2 (set Mozart), 7/10 patients (70%) had a significant seizure reduction (specifically, ≥50% in 1/10; ≥75% in 4/10; 100% in 2/10). An overall more significant behavioral improvement including less irritability and tearfulness, reduced self-/heteroaggression, a better daytime vigilance, and nighttime sleep quality, was also reported in children from group 2. David Schultz, M.D. 804-615-3027